- Previous Close
5.91 - Open
5.92 - Bid 5.82 x --
- Ask 5.83 x --
- Day's Range
5.80 - 5.89 - 52 Week Range
4.50 - 7.17 - Volume
3,595,300 - Avg. Volume
6,864,465 - Market Cap (intraday)
4.754B - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.02 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 12, 2018
- 1y Target Est
--
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence; mass spectrometry and separation analysis, life sciences related consumables, and ICP spectroscopy. The company was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Group Co., Ltd. in August 2021. Beijing Bohui Innovation Biotechnology Group Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.
www.bohui-tech.comRecent News: 300318.SZ
View MorePerformance Overview: 300318.SZ
Trailing total returns as of 3/11/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300318.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300318.SZ
View MoreValuation Measures
Market Cap
4.83B
Enterprise Value
5.71B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.46
Price/Book (mrq)
3.47
Enterprise Value/Revenue
6.45
Enterprise Value/EBITDA
60.91
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.73%
Return on Assets (ttm)
1.12%
Return on Equity (ttm)
1.96%
Revenue (ttm)
885.39M
Net Income Avi to Common (ttm)
-15.35M
Diluted EPS (ttm)
-0.02
Balance Sheet and Cash Flow
Total Cash (mrq)
118.36M
Total Debt/Equity (mrq)
42.04%
Levered Free Cash Flow (ttm)
-228.66M